Researchers have found a new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant in California, USA. This variant is more
Read moreefficacy
New molecule passes toxicology testing to treat multiple sclerosis
Brazilian researchers who study a native venomous fish have confirmed a route to drug development for the treatment of chronic
Read moreScientists find evidence of monoclonal antibodies’ efficacy in fighting malarial infection
Scientists at Walter Reed Army Institute of Research, in a collaboration the Duke University, have confirmed that monoclonal antibodies can
Read moreA SARS-CoV-2 spike protein adjuvant vaccine candidate produces durable rapid protection in vivo
The ongoing coronavirus disease 2019 (COVID-19) pandemic has spurred intensive vaccine-related research. As yet, no targeted, safe and effective antivirals
Read morecitalopram fluoxetine
A Hong Kong Baptist University-led (HKBU) research team has developed a novel drug which has the potential to become a
Read morePfizer-BioNTech SARS-CoV-2 vaccine effective for wide range of Covid-19–related outcomes
The Pfizer-BioNTech mRNA vaccine was shown to be 95% effective in preventing severe COVID-19 infection in clinical trials. However, given
Read moreCissampelos pareira L. extracts demonstrate anti-SARS-CoV-2 activity in vitro
A team of scientists from India has recently investigated the antiviral potency of a traditional medicinal plant Cissampelos pareira L.
Read morecheap propranolol online pharmacy without prescription
Extending the symptoms that trigger a PCR test for COVID-19 could help detect around a third more cases of the
Read morecheap actos next day no prescription
ESMO, the leading organization for medical oncology, has launched an important new service for rapidly disseminating research to accelerate the
Read moreArtemisia plant extracts show potential anti-SARS-CoV-2 activity in vitro
A team of scientists from Germany and the USA recently explored the effectiveness of traditional plant medicines in treating severe
Read more